Genelux Corporation Common Stock (GNLX) Live Share Price, Invest From India

Genelux Corporation Common Stock Stock Performance

as on April 24, 2026 at 6:57 am IST

Day's Low
Day's High
$2.48
Day's Price Range
$2.58
$2.51
1.20%
Downside
2.79%
Upside
52 Week's Low
52 Week's High
$2.26
52-Week Price Range
$8.54
$2.51
10.16%
Downside
240.04%
Upside

Genelux Corporation Common Stock share price movements today

Previous Close: $2.54
Open: $2.58
Volume: 589.4K
Day's Low - High: $2.48 - $2.58
52 Week Low - High: $2.26 - $8.54

Genelux Corporation Common Stock Historical Returns

1 Month Return: + 2.42 %
3 Month Return: -11.5 %
1 Year Return: -12.41 %
3 Year Return: -91.24 %
5 Year Return: 0 %

Genelux Corporation Common Stock Stock Fundamentals & Key Indicators

Check Genelux Corporation Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$113.8M

EPS (TTM)

-0.82

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-33.0M

Revenue (TTM)

8.0K

Profit Margin

0.00%

Return On Equity TTM

-170.00%

Genelux Corporation Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Genelux Corporation Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Genelux Corporation Common Stock	BUY	$113.8M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.2B	127.17%	131.81	8.45%
Vertex Pharmaceuticals Inc	BUY	$111.1B	100.86%	28.5	32.94%
BeiGene, Ltd.	NA	$34.7B	NA	126.48	5.37%
Regeneron Pharmaceuticals Inc	BUY	$79.0B	52.79%	18.02	31.41%

Stock Returns calculator for Genelux Corporation Common Stock Stock including INR - Dollar returns

The Genelux Corporation Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Genelux Corporation Common Stock investment value today

Current value as on today

₹95,410

Returns

-₹4,590

(-4.59%)

Returns from Genelux Corporation Common Stock Stock

-₹13,448 (-13.45%)

Dollar Impact

₹8,858 (+8.86%)

Analyst Recommendation on Genelux Corporation Common Stock Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Genelux Corporation Common Stock. Average target price of $17.5

Genelux Corporation Common Stock Share Price Target

Get share price movements and forecasts by analysts on Genelux Corporation Common Stock.

What analysts predicted

85.66%UPSIDE

Target Price

$17.5

Current Price

$2.51

Analyzed by

10 Analysts

Target

$17.50

Genelux Corporation Common Stock target price $17.5, a slight upside of 85.66% compared to current price of $2.51. According to 10 analysts rating.

Genelux Corporation Common Stock Stock’s Investor Sentiment and Interest

Search interest for Genelux Corporation Common Stock Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 25, 2026 to April 24, 2026

Change:-4% versus previous 30 day period

Genelux Corporation Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	1	0	-	-	0	0	-	-	0
Gross Profit	0	0	0	0	0	0	0	0	-	0
Operating Income	-5	-7	-8	-6	-6	-9	-7	-7	-8	-9
EBITDA	-5	-6	-7	-6	-6	-8	-7	-7	-7	-9
Interest Expense	0	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-6	-7	-6	-6	-8	-7	-7	-7	-9
Income Tax Expense	0	-4	0	-	-	-	-	-	-	-
Net Income	-5	-6	-7	-6	-6	-8	-7	-7	-7	-9
Net Profit Margin	0.00%	-462.23%	-98125.00%	0.00%	0.00%	-1001.79%	-1657.52%	0.00%	0.00%	-115587.50%

Genelux Corporation Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	11	0	0	0
Gross Profit	0	0	10	0	0	0
Operating Income	-12	-14	-3	-24	-31	-33
EBITDA	-11	-13	-1	-26	-28	-32
Interest Expense	1	1	1	3	-	-
Depreciation	0	0	0	1	0	0
Income Before Tax	-13	-16	-4	-28	-29	-32
Income Tax Expense	1	1	1	0	-	-
Net Income	-14	-17	-5	-28	-29	-32
Net Profit Margin	0.00%	0.00%	-47.05%	-16645.29%	-373362.50%	-401812.50%

Genelux Corporation Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-6	-7	-6	-6	-8	-7	-7	-7	-9
Operating Cash Flow	-6	-4	-6	-5	-4	-5	-7	-6	-6
Investing Cash Flow	-13	-1	-17	3	6	3	-2	4	6
Financing Cash Flow	0	0	27	-	0	9	0	-	0
Change in Cash	-20	-5	3	-1	2	7	-9	-1	0

Genelux Corporation Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-13	-16	-5	-28	-29	-32
Operating Cash Flow	-7	-6	-3	-20	-21	-25
Investing Cash Flow	0	0	0	-14	-8	12
Financing Cash Flow	18	0	0	44	28	9
Change in Cash	10	-6	-4	9	0	-3

Insights on Genelux Corporation Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 48.4% return, outperforming this stock by 139.6%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 28.4% return, outperforming this stock by 40.8%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -7.45M → -9.24M (in $), with an average decrease of 11.5% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 896.0K → 8.0K (in $), with an average decrease of 73.9% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, GNLX stock has moved down by -8.3%

About Genelux Corporation Common Stock

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec (olvimulogene nanivacirepvec), a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer. It also offers CHOICE, a technology and discovery and development platform; and developed an extensive library of isolated and engineered oncolytic VACV immunotherapeutic product candidates. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.

Organisation	Genelux Corporation Common Stock
Headquarters	2625 Townsgate Road, Westlake Village, CA, United States, 91361
Industry	Biotechnology
CEO	Mr. Thomas D. Zindrick J.D.
E-voting on shares	Click here to vote

Key Management of Genelux Corporation Common Stock

Name	Title
Dr. Jason B. Litten M.D.	Chief Medical Officer
Mr. Thomas D. Zindrick J.D.	Chairman, CEO & President
Dr. Joseph Cappello Ph.D.	Chief Technical Officer
Mr. Matthew Pulisic M.B.A.	CFO and Principal Financial & Accounting Officer
Mr. Eric Groen J.D.	General Counsel, Corporate Secretary, Chief Compliance Officer & Head of Business Development
Dr. Yong Yu Ph.D.	Senior Vice President of Clinical Development
Mr. Ralph Smalling B.Sc.	VP & Head of Regulatory Affairs

FAQs

What is Genelux Corporation Common Stock share price today?

Genelux Corporation Common Stock share price today is $2.51 as on April 24, 2026 at 1:27 am IST at the close of the market. Genelux Corporation Common Stock share today touched a day high of $2.58 and a low of $2.48.

What is the 52 week high and 52 week low for Genelux Corporation Common Stock share?

Genelux Corporation Common Stock share touched a 52 week high of $8.54 on November 5, 2025 and a 52 week low of $2.26 on May 7, 2025. Genelux Corporation Common Stock stock price today i.e. April 24, 2026 at 1:27 am IST is closed at $2.51,which is 70.59% down from its 52 week high and 11.31% up from its 52 week low.

What is Genelux Corporation Common Stock's market capitalisation today?

Genelux Corporation Common Stock market capitalisation is $0.00T as on April 24, 2026 at 1:27 am IST.

How to invest in Genelux Corporation Common Stock Stock (GNLX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Genelux Corporation Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genelux Corporation Common Stock Shares that will get you 0.5976 shares as per Genelux Corporation Common Stock share price of $2.51 per share as on April 24, 2026 at 1:27 am IST.

What is the minimum amount required to buy Genelux Corporation Common Stock Stock (GNLX) from India?

Indian investors can start investing in Genelux Corporation Common Stock (GNLX) shares with as little as ₹94.085 or $1 (as of April 24, 2026 at 3:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹940.85 in Genelux Corporation Common Stock stock (as per the Rupee-Dollar exchange rate as on April 24, 2026 at 3:40 am IST). Based on Genelux Corporation Common Stock share’s latest price of $2.51 as on April 24, 2026 at 1:27 am IST, you will get 3.9841 shares of Genelux Corporation Common Stock. Learn more about fractional shares .